SITC Cancer Immunotherapy CONNECT


SITC's Comprehensive Cancer Immunotherapy Training Program

Attend the SITC Cancer Immunotherapy Winter School on Jan. 13-17, 2020, in Houston.

Register to Attend Today

SITC Career Connections
Connecting talent seekers with job seekers at all career levels throughout the cancer immunotherapy field.

2019 SITC Logo Crop

Review Data Presented at SITC 2019! 
SITC's 34th Annual Meeting & Pre-Conference Programs received a record breaking number of abstracts. Now available, the SITC 2019 regular abstract supplement as published in the Journal for ImmunoTherapy of Cancer (JITC)!


JITC Increases Impact Factor to 8.676
The Journal for ImmunoTherapy of Cancer (JITC), SITC’s open access, peer-reviewed online journal, has increased its impact factor to 8.676.

New Online Patient Course Available: Understanding Cancer Immunotherapy 
Access SITC’s dedicated resource for patients and caregivers to learn about cancer immunotherapy

Now Available: SITC Cancer Immunotherapy Guidelines – Squamous cell carcinoma of the head and neck (HNSCC)
Learn up-to-date consensus recommendations for immunotherapy of head and neck cancers in this recently published SITC Cancer Immunotherapy Guidelines manuscript.

Stay Current with FDA-Approved Immunotherapy Treatments
Attend an upcoming SITC Advances in Cancer Immunotherapy™ Program 

Nashville, tenn. on dec. 4

San diego, Calif. on dec. 12

View More  Locations


NOW AVAILABLE: SITC's Guide to Managing Immunotherapy Toxicity

A new handbook from SITC for clinicians providing thorough coverage of the toxicity and management of adverse events for immune checkpoint inhibitors.

Purchase Today

2019 Lung Cancer and Immunotherapy Course 
A free, interactive course, part of the Advances in Cancer Immunotherapy™ online education series.

Register Now


Why I'm a SITC Member

Join Patrick Hwu, MD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.

Become a SITC Member


Inspire the Next Generation of Cancer Immunotherapy Leaders

Advance the science of cancer immunotherapy and help young investigators tackle hurdles facing the field with a gift to the SITC Forward Fund.

Donate Today


Explore resources and educational opportunities for cancer patients and those who advocate for them.







Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.







Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.






Latest Discussions

  • Dear All, I'll be attending SITC 2019 on November 7-8 and would like to network with anyone interested in or studying these topics. I'm new to the field of IO therapy and would appreciate any help making connections. Thanks, Rick ------------------------------ ...

    1 person recommends this.
  • Thank you for attending the Advances in Cancer Immunotherapy™ program in Boston, MA on October 10, 2019. We were pleased you could join us to take part in the education and networking opportunities this program provided. As a benefit of attending the ...

  • Profile Picture

    ACI Boston Syllabus

    Hello,  Thank you for attending the ACI this afternoon! I've attached the ACI Boston syllabus below.  Thank you, ------------------------------ Allison Joost Program Manager Society for Immunotherapy of Cancer (SITC) Milwaukee WI ----------------- ...

Follow the SITC Twitter Feed.


Connect with colleagues at these Upcoming Events.


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.


Learn More


The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More


Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.


Learn More